Skip to main content

Table 1 Characteristics of the controls and HFpEF patients

From: Association of serum total bilirubin levels with diastolic dysfunction in heart failure with preserved ejection fraction

 

Control group (n = 200)

HFpEF groups

  

1-mild (n = 52)

2-moderate (n = 116)

3-severe (reversible restrictive) (n = 138)

4-severe (fixed restrictive) (n = 21)

P*-value

Male (n, %)

116 (58%)

31 (5.6%)a

44 (37.9%)a

49 (35.5%)a

6 (28.6%)a,b,c,d

0.003

Age (years)

43.6 (9.7)

69.7 (7.3)a

65.9 (10.2)a

67.1 (11.4)a

66.3 (13.1)a

0.001

BMI (kg/m2)

22.7 (2.5)

24.3 (3.6)a

23.9 (4.7)

24.5 (2.1)a

23.8 (3.7)

0.048

Smoker (n, %)

85 (42.5%)

25 (48.1%)

39 (33.6%)

38 (27.5%)a

5 (23.8%)a,b,c

0.028

Medications

      

ASA (n, %)

0

48 (92.3%)a

110 (94.8%)a

134 (97.1%)a

20 (95.2%)a

<0.001

Diuretic (n, %)

0

21 (40.4)a

64 (55.2%)a,b

70 (50.7%)a,b

18 (85.7%)a,bc,d

<0.001

Beta blocker (n, %)

0

21 (40.4%)a

44 (37.9%)a

50 (36.2%)a

8 (38.1%)a

<0.001

ACEI/ARB (n, %)

0

47 (90.4%)a

112 (96.6%)a

133 (96.4%)a

21 (100%)a

<0.001

Statin (n, %)

0

50 (96.2%)a

111 (95.7%)a

132 (95.7%)a

19 (90.5%)a

<0.001

CCB (n, %)

0

27 (51.9%)a

52 (44.8%)a

66 (47.8%)a

9 (42.9%)a

<0.001

HR (b/min)

77.4 (6.1)

75.8 (6.7)

78.2 (7.1)

71.1 (5.8)a

80.2 (7.2)d

0.036

SBP (mmHg)

120.1 (8.6)

124.6 (5.8)

138.1 (10.1)a,b

140.2 (9.3)a,b

150.6 (7.2)a,b,c

0.005

DBP (mmHg)

78.2 (7.0)

80.3 (8.8)

81.2 (6.5)

90.2 (10.3)a,b,c

91.4 (9.5)a,b,c

0.017

Total cholesterol (mg/dl)

191.7 (19.1)

209.3 (20.2)a

234.7 (19.0)a

225.6 (18.8)a

242.5 (22.7)a

0.007

LDL (mg/dl)

108.3 (17.4)

124.1 (18.2)a

120.6 (19.1)a

125.7 (18.8)a

131.9 (21.2)a

0.004

HDL (mg/dl)

51.3 (7.5)

43.4 (8.2)

44.0 (8.1)

47.9 (6.3)

45.2 (7.7)

0.069

Triglyceride (mg/dl)

128.8 (19.4)

150.9 (17.3)a

152.6 (18.4)a

147.6 (20.5)a

144.1 (19.6)a

0.025

Fasting glucose (mg/dl)

95.2 (7.3)

96.3 (8.1)

100.7 (6.8)

94.9 (7.4)

102.5 (8.2)

0.326

Creatinine (umol/L)

83.6 (10.7)

92.4 (11.1)

95.3 (9.6)

121.3 (12.5)a,b,c

127.6 (13.5)a,b,c

0.013

Urea level (umol/L)

261.4 (23.9)

252.4 (22.1)

274.5 (19.3)

282.6 (20.7)

288.2 (21.6)

0.204

Alanine aminotransferase (U/L)

25.4 (6.4)

32.1 (7.9)

29.6 (8.1)

30.1 (6.4)

32.1 (7.5)

0.338

TB (umol/L)

15.3 (4.1)

14.1 (3.2)

12.5 (3.6)a

11.8 (2.9)a

10.4 (4.0)a,b

0.001

  1. Values are mean ± SD or numbers. BMI, body mass index; HR, heart rate; ASA: acetylsalicylic acid; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin II receptor blocker; CCB: calcium channel blocker; SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL, low density lipoprotein; HDL, high density lipoprotein; TB, total bilirubin; Numerical variables were compared by t-test; Categorical variables (male/female, smoker, medications) were compared by chi-square test. P*-value, control group vs. HFpEF group; aP < 0.05 compared with control, after Bonferroni correction; bP < 0.05 compared with stage 1-mild, after Bonferroni correction; cP <0.05 compared with stage 2-modeate, after Bonferroni correction; dP < 0.05 compared with stage 3-severe (reversible restrictive), after Bonferroni correction.